These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39429679)

  • 21. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
    Covert D; Robin AL
    Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latanoprost in the treatment of glaucoma.
    Alm A
    Clin Ophthalmol; 2014; 8():1967-85. PubMed ID: 25328381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021.
    Jiang T; Su H; Xu J; Li C; Zhang N; Li Y; Wu Y; Ni R; Ming Y; Li Z; Li L; Liu Y
    Ther Adv Drug Saf; 2024; 15():20420986231224227. PubMed ID: 38293566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study evaluating IOP changes after switching from a therapy with prostaglandin eye drops containing preservatives to nonpreserved tafluprost in glaucoma patients.
    Ranno S; Sacchi M; Brancato C; Gilardi D; Lembo A; Nucci P
    ScientificWorldJournal; 2012; 2012():804730. PubMed ID: 22606063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-year treatment patterns among new initiators of topical prostaglandin analogs.
    Schmier JK; Covert DW; Robin AL
    Curr Med Res Opin; 2009 Apr; 25(4):851-8. PubMed ID: 19231912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma.
    Li J; Lin X; Yu M
    Eur J Ophthalmol; 2015; 25(1):18-26. PubMed ID: 25044139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.
    Choi HY; Lee JE; Lee JW; Park HJ; Lee JE; Jung JH
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):146-52. PubMed ID: 22107041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
    Mishra D; Sinha BP; Kumar MS
    Korean J Ophthalmol; 2014 Oct; 28(5):399-407. PubMed ID: 25276082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.
    El Hajj Moussa WG; Farhat RG; Nehme JC; Sahyoun MA; Schakal AR; Jalkh AE; Abi Karam MP; Azar GG
    J Ophthalmol; 2018; 2018():1319628. PubMed ID: 29707390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost.
    García-Feijoo J; Muñoz-Negrete FJ; Hubatsch DA; Rossi GC
    Clin Ophthalmol; 2016; 10():2085-2091. PubMed ID: 27799736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
    Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
    Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.
    Park J; Cho HK; Moon JI
    Jpn J Ophthalmol; 2011 Jan; 55(1):22-7. PubMed ID: 21331688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma.
    Sharif NA; Odani-Kawabata N; Lu F; Pinchuk L
    Exp Eye Res; 2023 Apr; 229():109415. PubMed ID: 36803996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Clin Ophthalmol; 2017; 11():55-61. PubMed ID: 28053501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.
    Lee AJ; McCluskey P
    Clin Ophthalmol; 2010 Jul; 4():741-64. PubMed ID: 20689791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.
    Russ HH; Nogueira-Filho PA; Barros Jde N; Faria NV; Montiani-Ferreira F; Gomes JÁ; Mello PA
    Clinics (Sao Paulo); 2013 Oct; 68(10):1318-24. PubMed ID: 24212838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin analogues signal detection by data mining in the FDA Adverse Event Reporting System database.
    Contreras-Salinas H; Romero-López MS; Olvera-Montaño O; Rodríguez-Herrera LY
    BMJ Open Ophthalmol; 2024 Aug; 9(1):. PubMed ID: 39209740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin analog treatment of glaucoma and ocular hypertension.
    Alexander CL; Miller SJ; Abel SR
    Ann Pharmacother; 2002 Mar; 36(3):504-11. PubMed ID: 11895065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.